Quest Diagnostics Inc (NYSE:DGX)
$ 136.94 1.3 (0.96%) Market Cap: 15.21 Bil Enterprise Value: 20.09 Bil PE Ratio: 18.43 PB Ratio: 2.36 GF Score: 84/100

Quest Diagnostics Inc at Robert W Baird Global Healthcare Conference Transcript

Sep 05, 2019 / 03:25PM GMT
Release Date Price: $102.72 (-0.01%)
Eric White Coldwell
Robert W. Baird & Co. Incorporated, Research Division - Senior Research Analyst

Good morning, everyone. Nice to see you again. My name is Eric Coldwell. I cover pharma services, health care supply chain with Baird and it's a pleasure to have all star cast from Quest with us here this morning.

Stephen H. Rusckowski
Quest Diagnostics Incorporated - Chairman, President & CEO

Thank you for having us.

Eric White Coldwell
Robert W. Baird & Co. Incorporated, Research Division - Senior Research Analyst

Steve, thank you very much. This is Stephen Rusckowski, the -- obviously, the CEO of the firm; Jim Davis, EVP and General Manager of Diagnostics; and of course, we have Shawn Bevec, the VP of IR.

For those of who aren't overly familiar, Quest is a leading provider of clinical laboratory services and associated testing. The company has a national network consisting of thousands of Patient Service Centers and other testing access sites, collection sites and really an industry-leading

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot